JOHNNY PATTERSON: Open Payments
NPI 1336550508 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 41 payments from 13 companies in 2025. Trend: 2023 $25 · 2024 $484 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $219 |
| Lundbeck LLC | 6 | $173 |
| Tris Pharma Inc | 2 | $87 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Corium, LLC | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
Products named: REXULTI, VRAYLAR, Dyanavel XR, INGREZZA, Auvelity, TRINTELLIX, CAPLYTA, Azstarys.
Industry payments across OK — which companies pay providers there.
